HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip B Miner Selected Research

plecanatide

1/2023Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide.
2/2020Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
1/2019Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.
2/2018Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome.
1/2017A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip B Miner Research Topics

Disease

10Heartburn (Pyrosis)
11/2018 - 02/2002
8Constipation
01/2023 - 04/2006
6Gastroesophageal Reflux (GERD)
11/2014 - 02/2002
4Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/2020 - 04/2006
4Pain (Aches)
01/2011 - 01/2005
2Inflammation (Inflammations)
01/2011 - 10/2008
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2012
1Stomach Ulcer (Gastric Ulcer)
01/2011
1Duodenal Ulcer (Curling's Ulcer)
01/2011
1Ulcerative Colitis
10/2008
1Pouchitis
10/2008
1Hypersensitivity (Allergy)
08/2008
1Dyspepsia (Indigestion)
08/2008
1Rhinitis
05/2006
1Headache (Headaches)
05/2006

Drug/Important Bio-Agent (IBA)

8AcidsIBA
11/2018 - 02/2002
5plecanatideIBA
01/2023 - 01/2017
5Proton Pump InhibitorsIBA
11/2014 - 05/2008
3Esomeprazole (Nexium)FDA Link
11/2018 - 05/2006
2AntacidsIBA
06/2014 - 11/2004
2tegaserod (Zelnorm)FDA Link
08/2008 - 04/2006
2Omeprazole (Prilosec)FDA LinkGeneric
05/2008 - 02/2002
1bile acid binding proteinsIBA
08/2018
1elobixibatIBA
08/2018
1Guanylate Cyclase (Guanylyl Cyclase)IBA
01/2017
1uroguanylinIBA
01/2017
1Aminobutyrates (Aminobutyric Acid)IBA
11/2014
1lesogaberanIBA
11/2014
1Analgesics (Analgesic Drugs)IBA
06/2014
1acceleratory factor from growth hormone (AcG)IBA
06/2014
1Nonprescription Drugs (Patent Medicines)IBA
05/2014
1AntibodiesIBA
05/2012
1Clostridium difficile toxB proteinIBA
05/2012
1LubiprostoneFDA Link
09/2011
1Chloride Channels (Chloride Channel)IBA
09/2011
1Naproxen (Naprosyn)FDA LinkGeneric
01/2011
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2011
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2008
1Rabeprazole (Aciphex)FDA Link
05/2008
1Pantoprazole (Protonix)FDA LinkGeneric
05/2006
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2005
1Bile Acids and Salts (Bile Acids)IBA
01/2005
1Chenodeoxycholic Acid (Chenix)FDA Link
01/2005
1CalciumIBA
11/2004
1Calcium Carbonate (Limestone)FDA Link
11/2004
1Phenobarbital (Luminal)FDA Link
11/2004
1Ranitidine (Zantac)FDA LinkGeneric
02/2002

Therapy/Procedure

4Therapeutics
11/2018 - 07/2008
1Aftercare (After-Treatment)
07/2014
1Enema (Enemas)
10/2008